The first dose, which is much smaller, prepares the immune system to respond more powerfully to the second, larger dose. This ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

ImmunityBio's stock has risen sharply this year. Read more on whether investors should look closely at shares or avoid the ...

MIT researchers have developed a new HIV vaccination method that generates a strong immune response with just two doses, one ...

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...

This year's recipients have been recognised for their work on the HIV epidemic, GLP-1-based drugs, and how DNA can stimulate ...

One of this year's coveted Lasker Awards has gone to Zhijian "James" Chen, a scientist behind a key immune-system discovery.

Emory researchers are the first to show unprecedented control of SIV replication and decay of viral reservoirs by combining a ...

The goal of eliminating HIV in people living with the virus is to achieve a durable and treatment-free cure. One strategy to eradicate the virus involves boosting immune responses, particularly ...